Sun Pharma Advanced Research Company Limited Share Price
Equities
SPARC
INE232I01014
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.21 INR | -0.50% |
|
+2.26% | -24.61% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 7.05TCr 83Cr 79Cr 74Cr 66Cr 117.08Cr 128.85Cr 916.18Cr 340.07Cr 2.89TCr 312.64Cr 305.64Cr 12TCr | P/E ratio 2023 |
-22.9x | P/E ratio 2024 | -30.9x |
|---|---|---|---|---|---|
| Enterprise value | 6.96TCr 82Cr 78Cr 73Cr 65Cr 115.49Cr 127.1Cr 903.71Cr 335.44Cr 2.85TCr 308.38Cr 301.48Cr 12TCr | EV / Sales 2023 |
22.8x | EV / Sales 2024 | 157x |
| Free-Float |
25.1% | Yield 2023 * |
-
| Yield 2024 | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Sun Pharma Advanced Research Company Limited
More press releases
| 1 day | -0.50% | ||
| 1 week | +2.26% | ||
| Current month | -0.12% | ||
| 1 month | +5.40% | ||
| 3 months | -2.07% | ||
| 6 months | +2.13% | ||
| Current year | -24.61% |
1 week
203.10
221.00
1 month
189.75221.00
Current year
189.75472.80
1 year
189.75472.80
3 years
162.10472.80
5 years
81.00472.80
10 years
81.00598.00
| Director | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 24/04/2014 | |
| Chief Operating Officer | - | 26/07/2024 | |
| Compliance Officer | - | 22/09/2023 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 09/11/2009 | |
| Director/Board Member | 63 | 04/06/2007 | |
| Director/Board Member | 71 | 31/10/2014 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 92 M€ | +17.17% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -0.50% | +2.26% | -20.86% | -15.05% | 83Cr | ||
| +0.56% | +5.93% | +36.94% | +222.66% | 72TCr | ||
| +1.24% | +3.85% | +13.84% | +123.77% | 48TCr | ||
| -0.14% | -0.63% | -2.26% | -1.46% | 37TCr | ||
| -0.63% | +2.66% | +26.75% | +55.53% | 32TCr | ||
| -1.01% | -0.54% | -2.75% | +36.16% | 25TCr | ||
| -0.41% | +1.51% | +3.61% | -29.55% | 23TCr | ||
| -0.30% | +1.13% | +7.93% | +26.37% | 21TCr | ||
| +1.83% | +2.67% | +4.93% | +31.51% | 21TCr | ||
| -1.69% | -5.41% | +2.07% | +38.24% | 15TCr | ||
| Average | +0.22% | +1.82% | +7.02% | +48.82% | 29.51TCr | |
| Weighted average by Cap. | +0.36% | +2.31% | +14.96% | +87.27% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 238.78Cr 2.82Cr 2.69Cr 2.5Cr 2.23Cr 3.96Cr 4.36Cr 31Cr 12Cr 98Cr 11Cr 10Cr 420.33Cr | 76Cr 89.15L 84.95L 79.03L 70.5L 1.25Cr 1.38Cr 9.82Cr 3.64Cr 31Cr 3.35Cr 3.27Cr 132.98Cr |
| Net income | -222.58Cr -2.63Cr -2.5Cr -2.33Cr -2.08Cr -3.7Cr -4.07Cr -29Cr -11Cr -91Cr -9.87Cr -9.65Cr -391.82Cr | -387.21Cr -4.57Cr -4.35Cr -4.05Cr -3.61Cr -6.43Cr -7.08Cr -50Cr -19Cr -158.67Cr -17Cr -17Cr -681.62Cr |
| Net Debt | -386.8Cr -4.56Cr -4.35Cr -4.05Cr -3.61Cr -6.42Cr -7.07Cr -50Cr -19Cr -158.5Cr -17Cr -17Cr -680.89Cr | -96Cr -1.13Cr -1.08Cr -1Cr -89.57L -1.59Cr -1.75Cr -12Cr -4.63Cr -39Cr -4.26Cr -4.16Cr -168.95Cr |
More financial data
* Estimated data
Employees
409
Sector
Pharmaceuticals
Calendar
10/02/2025
- Q3 2025 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/24/03 | 216.21 ₹ | -0.50% | 604,997 |
| 02/24/02 | 217.29 ₹ | +0.38% | 1,038,236 |
| 29/24/29 | 216.47 ₹ | +6.03% | 1,221,487 |
| 28/24/28 | 204.15 ₹ | -2.33% | 646,686 |
| 27/24/27 | 209.02 ₹ | -1.14% | 531,890 |
Delayed Quote NSE India S.E., December 03, 2024 at 05:19 pm IST
More quotes
Net sales - Rate of surprise
- Stock Market
- Equities
- SPARC Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition